Status:
NOT_YET_RECRUITING
De-escalating Axillary Surgery in Breast Cancer Patients in Nigeria
Lead Sponsor:
Nova Scotia Health Authority
Collaborating Sponsors:
Obafemi Awolowo University
Conditions:
Breast Cancer
Axilla; Breast
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
In sub-Saharan Africa, breast cancer patients often present with advanced disease. In my previous research which evaluated over 600 patients from a prospective institutional data base, about 64% of wo...
Detailed Description
The overall goal of my research is to promote the delivery of guideline-concordant breast cancer care to Nigerian breast cancer patients in a pragmatic manner. This project is novel in that the invest...
Eligibility Criteria
Inclusion
- Eligible to receive systemic chemotherapy
- Must include all the following:
- Tany, cN1 at presentation
- Biopsy proven pN1 disease after axillary US
- cN0 after neoadjuvant chemotherapy
Exclusion
- Previous / recurrent breast cancer
- Previous axillary and/or breast surgery
- Inflammatory breast cancer
- N2 disease or Stage IV disease
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06039956
Start Date
November 1 2025
End Date
May 31 2027
Last Update
August 22 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.